New London VA Outpatient Clinic 4 Shaws Cv STE 101, New London, CT 06320 8604373611 (phone), 8604371801 (fax)
East Haven Counseling & Community Services 595 Thompson Ave, East Haven, CT 06512 2034683297 (phone), 2034683334 (fax)
VA Connecticut Healthcare System Psychiatry 950 Campbell Ave Blg1 Fl7, New Haven, CT 06516 2039325711 (phone), 2039373886 (fax)
Languages:
English Spanish
Description:
Dr. Lin works in East Haven, CT and 2 other locations and specializes in Psychiatry. Dr. Lin is affiliated with VA Connecticut Healthcare System West Haven Campus and Yale-New Haven Childrens Hospital.
Hong Lin - Collegeville PA, US Juan I. Luengo - Collegeville PA, US Ralph A. Rivero - Collegeville PA, US Mark James Schulz - Collegeville PA, US Ren Xie - Collegeville PA, US Jin Zeng - Collegeville PA, US
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
A61K 31/535 C07D 413/14
US Classification:
5142342, 544117
Abstract:
This invention relates to novel compounds of formula (I):.
Invented are novel pyridine compounds, the use of such compounds as inhibitors of PKB/AKT kinase activity and in the treatment of cancer and arthritis.
Thomas Wen Fu Ku - Collegeville PA, US Hong Lin - Collegeville PA, US Juan I. Luengo - Collegeville PA, US Robert W. Marquis Jr. - Collegeville PA, US Joshi M. Ramanjulu - Collegeville PA, US Robert Trout - Collegeville PA, US Dennis S. Yamashita - Collegeville PA, US
Jerry Leroy ADAMS - Collegeville PA, US Thomas H. Faitg - Collegeville PA, US Neil W. Johnson - Collegeville PA, US Hong Lin - Collegeville PA, US
International Classification:
A61K 31/497 C07D 401/12 A61K 31/4439 C07D 401/14
US Classification:
51425309, 5462754, 514341, 544364
Abstract:
The present invention relates to a compound of formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, Q, Z, and p are as described herein. Compounds of the present invention are useful for the treatment of cancers.
Invented are novel hetero-pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Hong Lin - Collegeville PA, US Meagan B. Rouse - Collegeville PA, US Mark A. Seefeld - Collegeville PA, US Dennis S. Yamashita - Wayne PA, US Ren Xie - Collegeville PA, US
Invented are novel pyrrole compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
The present invention relates to a compound of formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, Q, Z, and p are as described herein. Compounds of the present invention are useful for the treatment of cancers.
Jerry ADAMS - Collegeville PA, US Thomas Faitg - Collegeville PA, US Neil Johnson - Collegeville PA, US Jiri Kasparec - Collegeville PA, US Hong Lin - Collegeville PA, US Mark Mellinger - Collegeville PA, US Xin Peng - Collegeville PA, US Ren Xie - Collegeville PA, US
The present invention relates to a compound of formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, Q, Z, and p are as described herein. Compounds of the present invention are useful for the treatment of cancers.